Examples of using Mpa in English and their translations into Finnish
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
The change in predose level may not accurately represent changes in overall MPA exposure.
MPA(mycophenolic acid) is the active metabolite of mycophenolate mofetil.
MPA who has examined the market warn that the products can be fatal.
Money-Back Guarantee: MPA offers their students a 30 day money-back guarantee.
MPA has conducted its own survey of websites that caters to Swedish consumers.
MPA who have reviewed market warn that the products can be deadly.
MPA can progress quickly.
Following intravenous administration, mycophenolate mofetil undergoes rapid and complete metabolism to the active metabolite, MPA.
The nozzle vacuum is not set properly(for MPA);
IMPA then degrades into methylphosphonic acid(MPA), which can also be produced by other organophosphates.
In vivo, MPAG is converted back to free MPA via enterohepatic recirculation.
A negligible amount of substance is excreted as MPA(< 1% of dose) in the urine.
But we should bear in mind that a positive list would not include MPA.
In contrast, if concomitant ciclosporin treatment is stopped, an increase in MPA AUC of around 30% should be expected.
Where necessary, continue working on EU-level support mechanisms for the effective enforcement and control of MPA management measures;
As a result of enterohepatic recirculation, secondary increases in plasma MPA concentration are usually observed at approximately 6- 12 hours post-dose.
Lymphocyte Depleting Therapies and MPA: As the total burden of immunosuppression is a risk factor for malignancies
This dose achieved MPA AUC values similar to those seen in adult renal transplant patients receiving CellCept at a dose of 1 g bid in the early and late post- transplant period.
It should be noted that MPA coverage has further increased since 2012,
Food had no effect on the extent of absorption(MPA AUC) of mycophenolate mofetil when administered at doses of 1.5°g BID to renal transplant patients.